Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 160968-99-0 | MDL No. : | MFCD11181824 |
Formula : | C8H7F3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VDWGLBLCECKXRU-UHFFFAOYSA-N |
M.W : | 192.14 | Pubchem ID : | 13085347 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 39.96 |
TPSA : | 29.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.75 cm/s |
Log Po/w (iLOGP) : | 1.79 |
Log Po/w (XLOGP3) : | 2.43 |
Log Po/w (WLOGP) : | 3.59 |
Log Po/w (MLOGP) : | 1.95 |
Log Po/w (SILICOS-IT) : | 2.23 |
Consensus Log Po/w : | 2.4 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.71 |
Solubility : | 0.378 mg/ml ; 0.00197 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.69 |
Solubility : | 0.391 mg/ml ; 0.00203 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.86 |
Solubility : | 0.267 mg/ml ; 0.00139 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.3 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With boron tribromide In dichloromethane for 2 h; | A 1 M solution of boron tribromide (30 mL, 0.03 mol) in CH2Cl2 was added to a solution ofintermediate 2 (4.3 g, 0.02 mol) in anhydrous CH2Cl2 (50 mL) at -20 °C. The reaction mixture waswarmed to room temperature and, after, quenched by addition of excess saturated aqueous sodiumbicarbonate solution (40 mL). The organic layer was dried over Na2SO4, filtered, and concentratedunder reduced pressure. The crude material was sufficiently pure to be used directly in the next step(yield 98percent). Yellow oil (3.8 g); UPLC/MS purity 99percent, tR = 5.37. C8H7F3O2, MW 192.14, MonoisotopicMass 192.04, [M + H]- 191.0. 1H-NMR (300 MHz, CDCl3) δ 4.36 (q, J = 8.4 Hz, 2H, O–CH2–CF3),6.81–7.11 (m, 4H, Ar–H), 9.72 (br.s., 1H, O–H). 13C-NMR (75 MHz, CDCl3) δ 56.2, 68.1, 119.2, 121.5,122.4, 123.7, 126.4, 127.3, 136.4 |
[ 106854-77-7 ]
1-Bromo-4-(2,2,2-trifluoroethoxy)benzene
Similarity: 0.73
[ 27914-56-3 ]
4-(2,2,2-Trifluoroethoxy)benzoic acid
Similarity: 0.61
[ 17515-77-4 ]
2-(Bromomethyl)-5-(trifluoromethyl)furan
Similarity: 0.60
[ 106854-77-7 ]
1-Bromo-4-(2,2,2-trifluoroethoxy)benzene
Similarity: 0.73
[ 3259-03-8 ]
2-(2-Ethoxyphenoxy)ethyl bromide
Similarity: 0.67
[ 4463-59-6 ]
1-(2-Bromoethoxy)-2-methoxybenzene
Similarity: 0.67
[ 106854-77-7 ]
1-Bromo-4-(2,2,2-trifluoroethoxy)benzene
Similarity: 0.73
[ 3259-03-8 ]
2-(2-Ethoxyphenoxy)ethyl bromide
Similarity: 0.67
[ 4463-59-6 ]
1-(2-Bromoethoxy)-2-methoxybenzene
Similarity: 0.67
[ 106854-77-7 ]
1-Bromo-4-(2,2,2-trifluoroethoxy)benzene
Similarity: 0.73
[ 27914-56-3 ]
4-(2,2,2-Trifluoroethoxy)benzoic acid
Similarity: 0.61
[ 17515-77-4 ]
2-(Bromomethyl)-5-(trifluoromethyl)furan
Similarity: 0.60
[ 710-18-9 ]
1-Methoxy-4-(trifluoromethoxy)benzene
Similarity: 0.60